Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease. In 2016 the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.

Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Hangzhou Pushai Pharmaceutical Technology Co., Ltd., established on 2012-10-29, Business scope includes technology development,Technical Services,technical consulting:medical products.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Nanjing Medical Technology Co., Ltd., established on 2012-01-17, Business scope includes research and development of medical technology,Transfer and Technology Consulting;bioengineering development;Biomedical software development and network services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Greenpharma SAS supplies research and development products and services. It specializes in natural substances and active molecule or ingredient discovery for the pharmaceutical, cosmetic and agro-food industries. The firm’s products include Greenpharma Natural Compound Library, Human Endogenous Ligand Library, Extract Library, Chemo- or Bio- Focused Libraries, and ambinter chemicals. Its services encompass research and development projects, extraction and purification of natural products, analytical and medicinal chemistry, and molecular modeling and informatics. The company was founded by Philippe Bernard in December 2000 and is headquartered in Orleans, France.

Nanjing Anggu Pharmaceutical Technology Co., Ltd., established on 2014-03-05, Business scope includes pharmaceutical products,Biological product,medical instruments,Technology development of health products,technical consulting,technology transfer,Technical Services;Chemical Products,Technology development of cosmetics,Sales,technical consulting,technology transfer,Technical Services;Enterprise Marketing Planning;market research;Conference and exhibition services;Class I medical device,Daily necessities,Office Supplies Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Hefei Meilikang Pharmaceutical Technology Co., Ltd., established on 2011-09-02, Business scope includes Chinese patent medicine,Western medicine,Health products,R&D of cosmetics,technical consulting,Services and Transfers;Medical Device II,Three types of sales;Medical equipment rental;stationery,Daily necessities,Health Supplies,Chemical raw materials(Does not contain dangerous goods),Sales of topical disinfectants;General Electronics,Instrumentation equipment and accessories,Sales of computer printers and accessories,repair,Serve;Electronic computer and software development,network integration,Promotion of machinery and equipment,consult,Serve;Realtor;interior and exterior decoration;Self-operated and agent import and export business of various commodities and technologies(Products and technologies restricted or prohibited by the state are excluded).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Northeast Pharmaceutical Group Co., Ltd ("Northeast Pharm" for short), established in 1946, is a large-scale comprehensive pharmaceutical enterprise in China. Northeast Pharm is dedicated to the establishment of the whole industrial chain from R&D, production, medical commerce to medical engineering service. With the development for more than half of a century, Northeast Pharm has 352 national registration approval number, 12 series, over 400 raw materials and finished products. Manufacturing capacity is more than 13 billion units annually. Sales network covers more than 100 countries and areas in the world. Creation is the source of vitality. They challenge the unknown and impossibility. Northeast Pharm has established a series of high-end science and technology platforms encompassing national technology center, medical industry research institute, designing institute, new drug incubation center, quality inspection center, post-doctoral scientific research station. Northeast Pharm has top-end experts and management personnel who enjoy great popularity in several fields, such as gynecology, andrology, intestine, cardiovascular, anti-AIDS, Narcotic psychotropic and anti-infection medicines. Northeast Pharm insists on developing high quality chemical medicine and biological medicine using the best quality raw materials and the most advanced technology. All the products meet the latest standards of Chinese Pharmacopoeia, European Pharmacopoeia and United States Pharmacopeia. Following the principle of "Everything for your health", Northeast Pharm is dedicating to continuous technology innovation and providing high quality products and professional services to their customers and partners in the pharmaceutical and nutritional business.

Sinopharm Group Yibin Pharmaceutical Co., Ltd., established on 1999-08-18, Business scope includes production:small volume injection,mixture,tablet,pill,hard capsule,Granules,oral solution,syrup,Powder,tincture,liquid extract,Decoction;API(Wear Huning,Berberine Hydrochloride,Ornithine Aspartate,Betahistine mesylate,Nevirapine,Ketoprofen,Amifostine,Anhydrous Sodium Sulfate,Moxifloxacin hydrochloride,Oxiracetam,Galantamine Hydrobromide,donepezil,trandolapril,Losartan Potassium,Bumetanide,Esomeprazole Sodium,Diacerein,febuxostat);Pharmaceutical Intermediates;Plant extracts;drinks(solid drink);kinds of food,beauty products,Technology transfer and technical consultation for pharmaceutical products.Self-operated and agent import and export business of various commodities.Domestic and foreign freight forwarders,Cargo handling and warehousing and leasing.Sales:biochemical drug,Chinese Herbal Medicine,Biological product,Chemical API,Antibiotic API,Chinese patent medicine,Chemicals,antibiotic preparation;Pre-packaged food,Wine products and related auxiliary products,Package,clothing,textile,rubber,Plastic products and raw materials,Chemical raw materials and products(Free of Hazardous Chemicals),Daily necessities,Office Supplies,electronic product,Lighting appliances,steel,building materials,metallic material,ore,Glass product,Electromechanical,Equipment,Cellulose Products,Wujinjiaodian,Agricultural and sideline products,Business Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Foshan Tengrui Pharmaceutical Technology Co., Ltd., established on 2016-04-15, Business scope includes services:biomedicine,New products in the field of health food,Research and development of new technologies,transfer,consultation service,Conference Services,Testing and technical services of medical equipment and equipment;Sales:biochemical reagents,Plant extracts,Class I medical device.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Tongjun Pharmaceutical Technology Co., Ltd., established on 2013-04-07, Business scope includes wholesale of chemical products(Excluding hazardous chemicals);drug development;electronic,Communication and Automatic Control Technology Research,to develop;Instrument wholesale;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Natural science research and experimental development;Medical Research and Experimental Development;New material technical consultation,communication service;New material technology development service;Biotechnology Consulting,communication service;Chemical Engineering Research Services;Electronics retail;Biotechnology Development Services;Materials Science Research,technology development;Manufacturing of organic chemical raw materials(Monitor Chemicals,Excluding hazardous chemicals);New material technology transfer service;Biotechnology Transfer Services;Manufacture of other synthetic materials(Monitor Chemicals,Excluding hazardous chemicals);Import and export(Excluding franchised products);Technology Import and Export;

Tianjin Taipu Pharmaceutical Co., Ltd., established on 2010-12-16, Business scope includes pharmaceutical production(Carry out business activities with a license);Pharmaceutical Intermediates,Chemical raw materials(Does not contain dangerous chemicals and flammable and explosive precursors)manufacturing,processing,Sales;Self-operated and agent goods and technology import and export;Raw and auxiliary materials(Free of Hazardous Chemicals,Flammable and explosive precursors),Equipment,Instrumentation,Sales of spare parts and company-produced products;Own house rental;property management;biology,Development of medical technology and products,consult,transfer,Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Runxin Technology Co., Ltd., established on 2013-11-18, Business scope includes pharmaceutical,medical instruments,Healthy food,cosmetic,Intermediates of veterinary drugs and new chemical products,Technology research and development of new technology,technology transfer,technical consulting,Technical Services;cosmetic,Wholesale and retail of daily necessities.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China.

Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of polypeptide drugs. On the basis of strict production management and quality control according to the GMP strictly, it breaks through the bottle-neck of the polypeptide drugs' large-scale production technology by means of introduction digestion, independent innovation, and any other patterns. Shenzhen Hybio Pharmaceutical has successively applied for 38 patents, with 5 patents for invention, 7 national new drug certificates, 5 new drug clinical trial permissions, and 45 drug registration letters. The drugs are mainly used to treat diseases such as digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, senile diseases, and more.